Sterling Bay Partnership Secures $290M Financing for Sorrento Mesa’s Pacific Center
Sterling Bay→Pacific Center
May 29, 2026
PAI Pharma has acquired Nivagen Pharmaceuticals, expanding its domestic sterile injectable manufacturing footprint and broadening its ready-to-use (RTU) product offering for the hospital market.
The deal is positioned as a platform expansion for PAI Pharma in the healthcare/pharmacy sector, focused on sterile injectable production capabilities and RTU accessibility for hospital customers.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sterling Bay→Pacific Center
May 29, 2026
Garner Health
May 29, 2026
Universal Health Services→Talkspace
May 29, 2026
Omniscient Neurotechnology
May 29, 2026
Ampersand Capital Partners
May 29, 2026